|
Market Cap (4-Jun) $16,057,089 (1,586th) |
Close (30-Jun) $0.375 |
Volume (30-Jun) 3,448 |
Shortsold (16-Aug) 1,155 (0.00%) (595th) |
|
52w High $0.79 |
52w Low $0.110 |
P/E - |
EPS -0.08 |
AGN released this announcement to the ASX on 17 November 2021, 8:15. The announcement is not marked as price sensitive, and is 16 page(s) in length and 2.77MB in size.
You can view all announcements from AGN and see how they appear on a price chart on the announcements page.
At the date of this announcement, AGN was 0.000% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 595th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (16 August 2024).
| Other Recent Announcements from AGN | |
|---|---|
| ARG-007 Protects Brain Cells in Moderate TBI Model | 22 June 2023, 8:19 |
| Becoming a substantial holder | 20 June 2023, 8:21 |
| Becoming a substantial holder | 13 June 2023, 17:34 |
| AGM Presentation | 17 November 2021, 8:15 |
| Positive Preclinical Data for ARG-007 Neuroprotection in HIE | 3 November 2021, 8:14 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 October 2021, 8:11 |
| Investor Presentation | 27 October 2021, 8:17 |
You must be logged in to post a reply.
